Published in Strahlenther Onkol on October 01, 1988
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys (2000) 2.33
Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study. Br J Cancer (2012) 1.90
Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol (2002) 1.68
Contiguous pattern spreading in patients with Hodgkin's disease. Radiother Oncol (1998) 1.55
Cellular basis of radiation-induced fibrosis. Radiother Oncol (1995) 1.52
Primary central nervous system (CNS) lymphoma in immunocompetent patients. Ann Hematol (2002) 1.46
Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg (1998) 1.46
Radiation induced CNS toxicity--molecular and cellular mechanisms. Br J Cancer (2001) 1.44
Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma. Radiother Oncol (1997) 1.43
[Gamma knife versus stereotactic linear accelerator. Utilization, clinical results and cost-benefit relations]. Radiologe (1996) 1.40
The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie (2002) 1.39
[Emergency rescue in accidents with HDR afterloading units]. Strahlenther Onkol (1999) 1.39
[Acute gastrointestinal side effects of radiotherapy. What is certain in the treatment?]. Strahlenther Onkol (1996) 1.38
Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer (2010) 1.37
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
Risk factors for venous thromboembolic events in cancer patients. Ann Oncol (2005) 1.32
[Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000]. Pneumologie (2001) 1.28
Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol (2002) 1.28
Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Photochem Photobiol (1998) 1.21
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol (1999) 1.20
Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol (1994) 1.18
Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol (1990) 1.17
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc Natl Acad Sci U S A (1999) 1.15
Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics (1994) 1.14
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Ann Oncol (2009) 1.12
Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res (1991) 1.12
Cerebral metastases in extrapulmonary cell carcinoma. Implications for the use of prophylactic cranial irradiation. Strahlenther Onkol (2012) 1.12
Limited disease of extra-pulmonary small cell carcinoma. Impact of local treatment and nodal status, role of cranial irradiation. Strahlenther Onkol (2012) 1.12
Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors. Int J Clin Pharmacol Ther (2002) 1.11
Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer (1996) 1.11
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol (2005) 1.11
Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors. Ann Oncol (2006) 1.10
Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol (1999) 1.10
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol (1996) 1.09
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors. Clin Cancer Res (1998) 1.09
[Chemotherapy in advanced sarcomas (author's transl)]. Dtsch Med Wochenschr (1981) 1.07
Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res (1996) 1.06
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours. Br J Cancer (2008) 1.06
Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys (2000) 1.06
Methods for analysis of censored tumor growth delay data. Radiat Res (1990) 1.05
Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). Br J Cancer (2004) 1.04
AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics (2005) 1.03
Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol (1998) 1.01
Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer (1994) 1.00
Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Oncogene (2000) 0.99
Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96. J Clin Oncol (2001) 0.99
Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer (2000) 0.99
Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology (2005) 0.98
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. Invest New Drugs (2010) 0.98
In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res (1999) 0.97
Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors. Cancer Treat Rev (1982) 0.97
Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene (2001) 0.97
The suppression of heterotopic ossifications: radiation versus NSAID therapy--a prospective study. J Arthroplasty (1998) 0.96
Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology (2006) 0.96
Treatment of early stage testicular seminoma. J Cancer Res Clin Oncol (2001) 0.95
Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay. Radiat Environ Biophys (2001) 0.94
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients. Br J Cancer (2008) 0.94
Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89. Klin Padiatr (1998) 0.93
Thermoradiotherapy for locally recurrent breast cancer with skin involvement. Int J Hyperthermia (2001) 0.93
Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer. J Clin Oncol (2002) 0.93
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Bone Marrow Transplant (2005) 0.92
Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol (1998) 0.92
Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation. Int J Radiat Oncol Biol Phys (1993) 0.92
PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology (2000) 0.91
Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors. J Neurooncol (2000) 0.91
TGF-beta1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol (2000) 0.91
The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol (1998) 0.90
Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology (1999) 0.90
[A new working shift model for anesthesiologists: an analysis 3 years after implementation]. Anaesthesist (2012) 0.89
Design and implementation of the stavudine parallel-track program. J Infect Dis (1995) 0.89
New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol (1990) 0.88
Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II. Radiother Oncol (1999) 0.88
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer (1999) 0.88
The role of radiotherapy in the treatment of craniopharyngioma--indications, results, side effects. Front Radiat Ther Oncol (1999) 0.87
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine. Ann Oncol (2007) 0.87
Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother Oncol (2001) 0.87
Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr (2004) 0.87
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma. Bone Marrow Transplant (2003) 0.87
Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer. Strahlenther Onkol (2012) 0.87
Radiation response in 10 high-grade human soft tissue sarcoma xenografts to photons and fast neutrons. Int J Radiat Oncol Biol Phys (1990) 0.86
Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial. Strahlenther Onkol (2013) 0.86
Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiother Oncol (1997) 0.86
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol (2000) 0.86
70 Gy or more: which dose for which prostate cancer? J Cancer Res Clin Oncol (2005) 0.86
Chemotherapy of metastatic seminoma. Br J Cancer (1985) 0.86
Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study. Int J Radiat Oncol Biol Phys (1997) 0.86
Radiotherapy of soft tissue sarcomas with neutrons or a neutron boost. Br J Radiol (1984) 0.86
The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene (1999) 0.86
Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors. Strahlenther Onkol (2012) 0.85
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors. Ann Oncol (2004) 0.85
Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand. Radiat Res (1998) 0.85
Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol (1998) 0.85
The underlying cellular mechanism of fibrosis. Kidney Int Suppl (1996) 0.85
Thermoradiotherapy of the chest wall in locally advanced or recurrent breast cancer with marginal resection. Int J Hyperthermia (2005) 0.85
Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy. Acta Oncol (2000) 0.85
Paclitaxel-induced radiation recall dermatitis. Ann Oncol (1996) 0.84